GNH USA

Europe — EMA

Islandski Lišaj Tad Pharma

GNH USA supplies Islandski Lišaj Tad Pharma (Lichen Islandicus Extractum), a herbal botanical for respiratory support. Request a quote for global supply.

Lichen Islandicus Extractum

Request sourcing

1
Pack/s

What is Lichen Islandicus Extractum?

Lichen Islandicus Extractum, the active ingredient in Islandski Lišaj Tad Pharma, is a herbal botanical presented as an oromucosal preparation for use. Its therapeutic profile is not established in conventional medicine, and it is currently investigated for potential applications in traditional health contexts.

GNH USA supplies Islandski Lišaj Tad Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU quality standards and is manufactured under GMP conditions.

What is Lichen Islandicus Extractum used for?

Islandski Lišaj Tad Pharma contains Lichen Islandicus Extractum, a botanical extract that has been studied in traditional medicine but lacks approved clinical indications.

- Traditional respiratory support: used historically to soothe throat discomfort. - Skin health: applied in folk remedies for minor irritations. - General wellness: included in formulations aimed at supporting overall vitality.

What are the side effects of Lichen Islandicus Extractum?

Adverse reactions to Islandski Lišaj Tad Pharma are not well documented, and reported events are limited to occasional mild responses.

Common Side Effects: - Mild oral irritation: transient tingling or burning sensation in the mouth. - Taste alteration: temporary change in flavor perception. - Gastrointestinal discomfort: mild nausea or stomach upset.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe mucosal inflammation: persistent ulceration of oral mucosa. - Anaphylaxis: rare systemic hypersensitivity requiring immediate medical attention.

What precautions apply to Lichen Islandicus Extractum?

When considering Islandski Lišaj Tad Pharma, general safety measures should be observed due to limited clinical data. - Assess allergy history: verify no known hypersensitivity to lichens or related botanicals. - Monitor oral tolerance: observe for irritation during initial use. - Avoid use in active oral lesions: postpone until healed. - Pregnancy and lactation: consult healthcare professional before use. - Concurrent herbal products: discuss potential additive effects with a clinician. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

What does Lichen Islandicus Extractum interact with?

Potential drug interactions with Lichen Islandicus Extractum have not been systematically studied; caution is advised when co‑administered with other agents.

Major Interactions (Avoid): - Immunosuppressants: possible reduction of efficacy due to unknown immunomodulatory effects. - Anticoagulants: theoretical risk of enhanced bleeding if extract influences platelet function.

Moderate Interactions (Monitor Closely): - Antihistamines: may mask mild allergic reactions. - Other oral botanicals: additive irritation of mucosa. - Cytochrome P450 substrates: unknown effect on metabolism; monitor therapeutic levels if applicable.

Frequently asked questions

What is Islandski Lišaj Tad Pharma used for?+
Islandski Lišaj Tad Pharma contains Lichen Islandicus Extractum, a botanical traditionally employed to soothe throat discomfort, support skin health, and promote general wellness. It is not approved for specific medical indications, and its use is generally guided by traditional practice rather than regulated therapeutic claims.
How does Lichen Islandicus Extractum work?+
The precise pharmacology of Lichen Islandicus Extractum is not fully defined. Laboratory studies suggest the extract may provide antioxidant effects and modulate inflammatory pathways in mucosal tissues, which could underlie its traditional use for soothing irritation. Human data confirming these mechanisms are currently limited.
What is the usual dose of Islandski Lišaj Tad Pharma?+
The dosage of Islandski Lišaj Tad Pharma is determined by the prescribing healthcare professional based on individual needs, formulation strength, and intended use. Patients should follow the specific instructions provided by their clinician and not alter the dose without medical guidance.
Is Islandski Lišaj Tad Pharma safe during pregnancy or breastfeeding?+
Safety data for Lichen Islandicus Extractum in pregnancy or lactation are insufficient. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using the product to weigh potential risks and benefits.
How do I order Islandski Lišaj Tad Pharma from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Islandski Lišaj Tad Pharma compare with other herbal respiratory supports?+
Compared with other botanical respiratory aids, Islandski Lišaj Tad Pharma offers an oromucosal delivery of Lichen Islandicus Extractum, which is distinct from inhaled or oral capsule forms. While both aim to soothe throat irritation, differences in extraction methods, dosage forms, and regulatory status may affect efficacy and safety profiles.
What are the storage and handling requirements for Islandski Lišaj Tad Pharma?+
The product should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keeping the container tightly sealed helps maintain stability and potency over its shelf life.
How is Islandski Lišaj Tad Pharma administered?+
Islandski Lišaj Tad Pharma is administered via the oromucosal route. The prescribed amount is placed in the mouth and allowed to dissolve or be held briefly, ensuring contact with the oral mucosa before swallowing, as directed by a healthcare professional.
What are the most serious risks associated with Islandski Lišaj Tad Pharma?+
Serious risks, although rare, include allergic reactions such as rash, swelling, or difficulty breathing, and severe mucosal inflammation that may lead to ulceration. Immediate medical attention is required if any signs of anaphylaxis or persistent oral lesions develop.
Who should not use Islandski Lišaj Tad Pharma?+
Individuals with known hypersensitivity to lichens or related botanical extracts should avoid the product. It is also contraindicated in patients with active oral lesions, uncontrolled asthma, or those taking immunosuppressive or anticoagulant therapy without medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Lichen Islandicus Extractum
Route
Oromucosal Use
Manufacturer
Tad Pharma Gmbh
Origin
EU

Related products